Apr 3 |
Biden and Senator Sanders to highlight efforts lower cost of asthma inhalers
|
Apr 1 |
UPDATE 1-Teva, Viatris win new chance to challenge J&J schizophrenia drug patent
|
Apr 1 |
Teva and Viatris revives chance to dispute J&J's schizophrenia drug patent
|
Apr 1 |
Teva, Viatris win new chance to challenge J&J schizophrenia drug patent
|
Apr 1 |
Teva and Launch Therapeutics collaborate for dual-action asthma rescue inhaler respiratory program
|
Apr 1 |
Clinical Collaboration Agreement between Teva and Launch Therapeutics to Accelerate Development of Dual-Action Asthma Rescue Inhaler (ICS-SABA/TEV-’248) Respiratory Program; Teva and Abingworth Enter Strategic Development Funding Agreement
|